The two have signed a Memorandum of Understanding to study how the technology developed by HHI can be used in the detection, diagnosis and treatment of medical conditions. Johns Hopkins University School of Medicine researchers with clinical expertise in a variety of specialty areas, including oncology and infectious diseases, will collaborate with HHI's scientists and engineers.
"Johns Hopkins is thrilled to partner with a proven global leader whose knowledge and experience matches our longstanding tradition of excellence in patient care and research," said Helen Montag of The Johns Hopkins University. "This partnership will allow us to introduce an emerging technology into the medical field to advance care for patients around the globe."
"This collaboration will leverage both of our organizations' best-in-class abilities to jointly develop new point-of-care clinical tools," said Frank Menzler, Fraunhofer Heinrich Hertz Institute's senior director for the US. "We are very excited to fuse Fraunhofer HHI's sensor technologies with Johns Hopkins' clinical experience."
Fraunhofer Heinrich Hertz Institute is one of 80 institutions affiliated with Fraunhofer-Gesellschaft and has research expertise ranging from optical communication networks, systems and components, to mobile broadband systems, electronic-imaging technologies and optical-sensor technologies.
From left to right: Hans-Joachim Grallert, Executive Director of Fraunhofer HHI; Frank Menzler, Senior Director USA for Fraunhofer USA; and Wesley D. Blakeslee, Executive Director, Office of Technology Transfer at Johns Hopkins University